First Do No Harm: Strategies for Managing Non-Cancer Pain in Your Clinic

Released On
May 24, 2022

Expires On
December 31, 2022

Media Type
Internet

Completion Time
120 minutes

Specialty
Emergency Medicine, Neurology, Obstetrics & Gynecology, Primary Care, Rheumatology, Surgery, Urology

Topic(s)
Pain

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Antidote Education Company and Albert Einstein College of Medicine-Montefiore Medical Center.

This activity is supported by an independent education grant from Opioid Analgesic REMS Program Companies.

Please see here for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Credit Available

  • Physicians — maximum of 2.0 AMA PRA Category 1 Credit(s)
  • Nurses — maximum of 2.0 Contact Hours
  • Pharmacists — maximum of 2.0 hours (0.20 CEUs) of continuing education credit
  • IPCE — maximum of 2 Interprofessional Continuing Education (IPCE) credits

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of physicians, nurse practitioners, physician assistants, nurses, pharmacists, and other healthcare professions caring for patients with pain.

Program Overview

This activity will help you apply the fundamentals of pain management – assessment, treatment, and management of patient with pain – both acute and chronic. Following 2 patient cases, this 4-part, short form, video-based activity, will provide strategies treat patients with pain while reducing serious adverse outcomes resulting from inappropriate prescribing, misuse, and abuse of opioid analgesics.

Each of the 4 30-minute episodes, will take you into an engaging learning environment. Experience the video content while gaining access to useful tools and resources available for download.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Perform an effective assessment of patients with pain to determine the most appropriate treatment options, including identification of patients at risk of abuse and addiction.
  • Create an effective pain treatment plan, including use of nonpharmacologic approaches and non-opioid pharmacotherapies as appropriate.
  • Initiate, modify, and discontinue opioid analgesic therapy in a safe manner.
  • Manage ongoing therapy for patients using opioid analgesic therapy, including modification of treatment strategies as needed to achieve adequate pain relief in the shortest duration.
  • Employ best-practices for counseling patients and caregivers about the safe and most effective use of opioid analgesic therapies.
  • Discuss the basic elements of addiction medicine, particularly opioid use disorder.

Faculty

Paul Christo, MD

Associate Professor
Division of Pain Medicine
Johns Hopkins University School of Medicine
Baltimore, MD
Director
Multidisciplinary Pain Fellowship Training Program
Blaustein Pain Treatment Center
Johns Hopkins Hospital
Baltimore, MD

Kristi Dively, DO, FACOOG

Medical Director
Retreat Behavioral Health
Ephrata, PA

Steven Stanos, DO

Executive Medical Director
Rehabilitation and Performance Medicine, Swedish Health System
Seattle, WA
Medical Director
Swedish Health System Pain Medicine and Services
Seattle, WA
Past President, Currently Secretary
American Academy of Pain Medicine (AAPM)
Serves on American Medical Association (AMA) Substance Use Disorder and Pain Task Force
Active with the AAPM and the American Academy of Physical Medicine and Rehabilitation
Editorial Board
Pain Medicine

Disclosures of Relevant Conflicts of Interest

Faculty

The following faculty, authors and content developers have disclosed a relevant financial relationship with ACCME-defined commercial interests during the past 24 months. All relationships have been mitigated.

Paul Christo, MD
  • Consultant: Eli Lilly, Exicure, GlaxoSmithKline, Y-mAbs Therapeutics
Steven Stanos, DO
  • Consultant: AppliedVR, Averitas Pharma, Emergent BioSolutions, Hisamitsu Pharmaceutical, Neurana Pharmaceutical
  • Speaker: Averitas Pharma

Kristi Dively, DO, FACOOG, has no relevant financial relationships with ACCME-defined commercial interests during the past 24 months.

Planners and Editors
The following have reported that they do not have any relevant financial relationships with ACCME-defined commercial interests during the past 24 months: Vamsi Ahobila, MD; Matthew Fleming; Michael Fleming, MD; and Morgan Leafe, MD, MHA.

Content Reviewers
The following content reviewers have reported that they do not have any relevant financial relationships with ACCME-defined commercial interests during the past 24 months: Michael Fleming, MD; Timothy Munzing, MD.

The following reviewers have disclosed relevant financial relationships with ACCME-defined commercial interests during the past 24 months. All conflicts of interest have been mitigated.
Kathleen O’Connor, BSN, RN (ownership in Eli Lilly and Johnson & Johnson)
Mark Sinnett, PharmD. (consultant for Mallincrodt and Pharmacosmos)

Physician Accreditation Statement

Antidote Education Company is accredited with Commendation by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Antidote Education Company designates this enduring activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Joint Accreditation Statement

In support of improving patient care, Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team

Nursing Continuing Education Credit Designation

Albert Einstein College of Medicine-Montefiore Medical Center designates this activity for 2 nursing contact hours. Nurses should claim only credit commensurate with the extent of their participation in the activity.

Pharmacists Accreditation Statement

Albert Einstein College of Medicine-Montefiore Medical Center designates this continuing education activity for 2 contact hour (.2 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - UAN JA4008224-9999-22-051-H05-P.

Type of Activity: Knowledge

Upon successfully completing the post-test with a score of 70% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Joint Accreditation Statement

This activity was planned by and for the healthcare team, and learners will receive 2 Interprofessional Continuing Education (IPCE) credits* for learning and change.

*For physicians, this is the number of AMA PRA Category 1 Credits™ awarded.
*For non-physicians, this is the number of AMA PRA Category 1 Credits™ designated.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Submit the evaluation form.

Certificates will be emailed to the participant

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

Antidote Education Company and Albert Einstein College of Medicine-Montefiore Medical Center requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

Disclaimer

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Contact Information

For CME questions please contact Antidote Education Company registration@antidotecme.com